STAAR Surgical Co
NASDAQ:STAA
STAAR Surgical Co
Cash from Financing Activities
STAAR Surgical Co
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
STAAR Surgical Co
NASDAQ:STAA
|
Cash from Financing Activities
$7.4m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
12%
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Financing Activities
$116m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Financing Activities
-$307m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Financing Activities
-$598.3m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-34%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Financing Activities
-$13.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
See Also
What is STAAR Surgical Co's Cash from Financing Activities?
Cash from Financing Activities
7.4m
USD
Based on the financial report for Dec 29, 2023, STAAR Surgical Co's Cash from Financing Activities amounts to 7.4m USD.
What is STAAR Surgical Co's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
12%
Over the last year, the Cash from Financing Activities growth was -11%. The average annual Cash from Financing Activities growth rates for STAAR Surgical Co have been -28% over the past three years , -37% over the past five years , and 12% over the past ten years .